WCN'26: Hot Debate: Complement Inhibition vs Nefecon in IgA Nephropathy – Which First for Patients at Risk?

Recorded On: 03/29/2026

WCN'26: Hot Debate: Complement Inhibition vs Nefecon in IgA Nephropathy – Which First for Patients at Risk?

Key:

Complete
Failed
Available
Locked
Complement Inhibition Should Be Considered Before Nefecon in Patients With IgAN at Risk of Progression
Open to view video.
Open to view video.
You must register to access.
Nefecon Should Be Considered Before Complement Inhibition in Patients With IgAN at Risk of Progression
Open to view video.
Open to view video.
You must register to access.